Stem cell bond issue has narrow lead in poll
By Associated Press,
Associated Press
| 10. 11. 2004
A controversial measure that would provide $3 billion in state bond money to pay for human embryonic stem cell research holds a narrow margin of support among voters, according to a new Field Poll.
Proposition 71, designed to get around the Bush administration's funding limits on such research, would authorize the state to sell bonds to provide annual payments of about $300 million to scientists and companies doing stem cell research.
The poll found that 46 percent of likely voters support the idea with 39 percent opposed and 15 percent undecided. The margin of error was 4.3 percentage points.
The numbers are a slight improvement from an August poll that found 45 percent supported the bond measure to 42 percent opposed.
Supporters of the proposition -- including a coalition of influential Democratic donors and several Silicon Valley tycoons -- have raised more than $12 million for the campaign and are running TV ads.
The Field Poll found that half of those surveyed said they had seen or heard something about the initiative -- an improvement since August of 10 percentage...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...